SCT650C

DRUG3 trials

Sponsors

Sinocelltech Ltd.

Conditions

Autoimmune DiseaseAxial SpondyloarthritisHidradenitis Suppurativa (HS)

Phase 1

Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers

Sinocelltech Ltd.Autoimmune Disease

Start: 2023-06-30End: 2024-03-31Target: 32Updated: 2023-06-08

Phase 2

Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis

Not yet recruitingNCT06197009

Sinocelltech Ltd.Axial Spondyloarthritis

Start: 2024-07-01End: 2026-08-01Target: 168Updated: 2024-01-09

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

RecruitingNCT07244510

Sinocelltech Ltd.Hidradenitis Suppurativa (HS)

Start: 2025-12-16End: 2028-02-16Target: 60Updated: 2026-04-28